Skip to main content

Find Clinical Trials

Home
Conditions
Dyskinesias

Clinical trial condition

Dyskinesias

Explore clinical trials studying Dyskinesias. Study availability and eligibility vary by location and protocol.

123 public trials 15 recruiting studies

Refine in advanced search Browse all conditions

Dyskinesias trial results

Completed

Sarizotan in Parkinson Patients With L-dopa-induced Dyskinesia

NCT00314288

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +12 more
Locations: Fountain Valley, California, United States

Sunnyvale, California, United States

Miami, Florida, United States

Tampa, Florida, United States

View all 51 locations

View Trial Details

Completed

Onset Motor Complications Using REQUIP CR (Ropinirole Controlled-release) As Add-on Therapy To L-dopa In Parkinson's

NCT00363727

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +11 more
Locations: GSK Investigational Site Anniston, Alabama, United States

GSK Investigational Site Birmingham, Alabama, United States

GSK Investigational Site Birmingham, Alabama, United States

GSK Investigational Site Phoenix, Arizona, United States

View all 69 locations

View Trial Details

Completed

Prospective Evaluation of Forceplate Measured Levodopa-Induced Dyskinesia

NCT00912977

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +11 more
Locations: Oregon Health & Science University Portland, Oregon, United States

View Trial Details

Completed

Levetiracetam Treatment of L-dopa Induced Dyskinesias

NCT00076674

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +10 more
Locations: National Institute of Neurological Disorders and Stroke (NINDS) Bethesda, Maryland, United States

View Trial Details

Completed

Automated Telehealth Diagnostics for Remote Parkinson Monitoring

NCT02152319

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +13 more
Locations: University of Rochester Rochester, New York, United States

View Trial Details

Completed

Study of Safety, Tolerability, Pharmacokinetics, and Efficacy of ABT-SLV187 in Subjects With Advanced Parkinson's Disease

NCT01479127

Conditions: Advanced Parkinson's Disease, Central Nervous System Diseases, Dyskinesias, +5 more
Locations: Not specified

View Trial Details

Completed

Efficacy and Safety of AFQ056 in Reducing L-dopa Induced Dyskinesias in Parkinson's Disease Patients

NCT00888004

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +12 more
Locations: Novartis Investigative Site Dresden, Germany

Novartis Investigative Site Kassel, Germany

Novartis Investigative Site Leun-Biskirchen, Germany

Novartis Investigative Site Marburg, Germany

View Trial Details

Completed

Efficacy and Safety of JM-010 in PD With Levodopa-Induced Dyskinesia

NCT02439203

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +12 more
Locations: Bloemfontein, South Africa

View Trial Details

Completed

Kinesia HomeView - Home Diary Comparison

NCT01920425

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +13 more
Locations: Great Lakes NeuroTechnologies Inc Valley View, Ohio, United States

View Trial Details

Completed

An Exploratory Clinical Trial in Early Stage Huntington's Disease Patients With SEN0014196

NCT01485952

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +16 more
Locations: Universitätsklinik Ulm, Neurologie Ulm, Germany

View Trial Details